Thermalin Diabetes

BiotechnologySeries ACleveland, USthermalin.com

Latest round

Series A

Last raised

Mar 2011

Total raised

$3.1M

Investors

1

About Thermalin Diabetes

Thermalin Diabetes Inc.Thermalin Diabetes Inc. was founded in 2007 and is headquartered in Cleveland, US. The company develops thermal management solutions for electronic devices.9 mn.Thermalin Diabetes Inc. specializes in advanced thermal management solutions, primarily focusing on the development and distribution of innovative thermal interface materials (TIMs) and heat spreaders. Their core product offerings are designed to enhance heat dissipation in electronic devices, thus improving overall performance and reliability. The TIMs function by filling air gaps between heat-generating components and heat sinks, ensuring efficient thermal transfer. Targeted end users include manufacturers of consumer electronics, automotive systems, and industrial equipment, particularly in high thermal efficiency sectors such as telecommunications and computing.The company generates revenue through a B2B model, primarily engaging with OEMs and component manufacturers who require high-performance thermal materials for their products. Transactions typically involve bulk orders of thermal interface materials and heat spreaders, with clients providing forecasts for their production needs. Pricing structures are determined based on product specifications, volume, and contractual agreements. For instance, flagship products include proprietary thermal interface solutions priced according to thermal conductivity and application suitability, with potential discounts for long-term contracts or high-volume orders.Thermalin Diabetes Inc.9 mn to innovate and expand its product line. New thermal materials are in development, with expected launches in the upcoming fiscal year. Additionally, the company plans to target expansion into the Asian markets and other emerging regions by the end of 2025, enhancing its global footprint.

Who invested in Thermalin Diabetes

1 investor across 2 rounds

See all investors in Thermalin Diabetes

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Mar 28, 2011

    Amount

    $2.9M

    Investors

    Locked

  2. Seed

    Mar 29, 2010

    Amount

    $0.3M

    Investors

    Locked

Questions about Thermalin Diabetes

Who invested in Thermalin Diabetes?

Thermalin Diabetes has 1 investor on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Thermalin Diabetes raised?

Thermalin Diabetes has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Thermalin Diabetes last raise money?

Thermalin Diabetes's most recent round on record is a Series A, in Mar 2011.

What does Thermalin Diabetes do?

Thermalin Diabetes is a biotechnology company.

Where is Thermalin Diabetes headquartered?

Thermalin Diabetes is headquartered in Cleveland, US.

Which VCs invest in companies like Thermalin Diabetes?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Thermalin Diabetes's stage. Their profiles are linked below.

Raising like Thermalin Diabetes? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.